Does addition of a new physiotherapy intervention improve outcomes for patients with low back pain?
- Conditions
- ow back painLow back painMusculoskeletal - Other muscular and skeletal disordersPhysical Medicine / Rehabilitation - Physiotherapy
- Registration Number
- ACTRN12611000757910
- Lead Sponsor
- niversity of Sydney
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
To take part in the trial, participants must meet all of the following criteria:
Primary area of complain extending from the 12th rib to the buttock crease.
New episode of LBP. This is defined as an episode which was preceded by a period of at least one month without LBP
LBP symptoms which have a score of 3/10 or more on numerical pain rating scale
Known or suspected serious spinal pathology Nerve root compromise evidenced by at least two of the following (i) myotomal weakness, (ii) dermatomal or widespread sensory loss, (iii) hypo or hyper-reflexia of the lower limb reflexes.
Spinal surgery within the preceding six months.
If currently receiving any other physical therapy for LBP
If pregnant or intending to become pregnant.
Currently taking medications that significantly alter gut motility
Currently taking medications such as oral cortico-steroids which are known to increase the risk of intestinal perforation
A known gastrointestinal disease that associates with a risk of intestinal perforation e.g. Crohn’s disease, diverticular disease, peptic ulcer disease
Known to be taking anti-platelet medications such as Warfarin and Clopidogrel
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ow back pain intensity, as measured by Numerical Pain Rating Scale.[6 weeks following entry into trial]
- Secondary Outcome Measures
Name Time Method ow back pain intensity, as measured by Numerical Pain Rating Scale.[Week 2 and Week 52];Disability as measured by Roland-Morris Disability Questionnaire[Week 2, 6 and 52];Function as measured by Patient Specific Functional Scale[Week 2, 6 and 52]